HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting [NA]
Clinical trial update on brief alcohol intervention for HIV-infected men who have sex with men in primary care; study completed with results…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Social Media Based Peer-Led Intervention for HIV Prevention [NA]
A completed clinical trial evaluating a social media–based, peer-led intervention to improve HIV prevention and PrEP uptake; results posted …
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease [Phase 2]
Phase 2 clinical trial investigating targeted anticoagulation to reduce inflammation and cellular activation in long-term HIV disease has co…
-
CLINICAL_TRIALS trial_result · 2019-09-03Clinical Trial Update: Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects [Phase 2]
Phase 2 trial update evaluating dolutegravir with 2 NRTIs in treatment-naïve HIV-2 infected subjects has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-03Clinical Trial Update: Optimization of Darunavir Therapy and Dosage Recommendations [Phase 4]
Phase 4 clinical trial update studying darunavir therapy optimization and dosage recommendations for HIV-1 infection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-08-29FDA Approved: LAMIVUDINE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approval of a supplemental application for lamivudine by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028) [Phase 2]
Phase 2 trial evaluating switching virologically suppressed HIV-1 participants from ATRIPLA to MK-1439A (doravirine/tenofovir disoproxil fum…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV) [Phase 4]
A Phase 4 clinical trial evaluating a simplified strategy for long-term management of HIV infection (Simpl'HIV).
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Scientific Evaluation of Peer Education and STD Treatment to Reduce the Spread of HIV in Zimbabwe [NA]
The trial evaluated peer education and sexually transmitted disease treatment strategies to reduce HIV transmission in Zimbabwe. The study i…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Cytomegalovirus Infection in Patients With HIV-1 Infection [Phase 3]
Phase 3 clinical trial update for cytomegalovirus infection in patients with HIV-1 infection has completed.
-
FDA approval · 2019-08-27FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA has approved a supplemental Abbreviated New Drug Application for Lamivudine and Zidovudine from Aurobindo Pharma Limited, enabling the g…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: RPV+DRV/Cobi Dual Therapy in Subjects With HIV Controlled Infection [Phase 4]
Phase 4 clinical trial update evaluating RPV+DRV/Cobi dual therapy in HIV-infected individuals.
-
FDA approval · 2019-08-21FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for NORVIR (ritonavir) submitted by AbbVie Inc.
-
FDA approval · 2019-08-21FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's supplemental application for nevirapine, expanding the availability of this antiretroviral generic. …
-
FDA approval · 2019-08-21FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc.
-
FDA approval · 2019-08-21FDA Approved: NEVIRAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Nevirapine (generic) from Mylan Pharmaceuticals Inc., authorizing a modification to an existing …
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy [Phase 2]
Phase 2 clinical trial of aramchol for HIV-associated nonalcoholic fatty liver disease and lipodystrophy has completed with results posted i…
-
FDA approval · 2019-08-21FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie.
-
FDA approval · 2019-08-21FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved AbbVie’s supplemental application for NORVIR (ritonavir). The approval updates the product’s labeling or uses as described …
-
FDA approval · 2019-08-16FDA Approved: ABACAVIR — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for abacavir sulfate by Rising Pharma Holdings, Inc. This action represents an additional regulatory…
-
FDA approval · 2019-08-16FDA Approved: ABACAVIR — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for ABACAVIR submitted by Aurobindo Pharma Limited.
-
FDA approval · 2019-08-14FDA Approved: NEVIRAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Nevirapine from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Evaluating Inflammatory and Immunological Changes of HIV-positive Patients Switching to DTG Dual Regimen Compared to Those Switching to a Triple Drugs Regimen (B/F/TAF) [Phase 4]
Phase 4 trial evaluating inflammatory and immunological changes in HIV-positive patients switching to DTG dual regimen versus B/F/TAF triple…
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Trial of Vitamin D in HIV Progression [Phase 3]
A Phase 3 clinical trial evaluating the effect of Vitamin D on HIV progression has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and Adolescents [Phase 3]
Phase 3 clinical trial examining the effects of calcium and high-dose vitamin D supplementation on bone mineral density in HIV-infected chil…